Amos Douvdevani

4.1k total citations
101 papers, 2.9k citations indexed

About

Amos Douvdevani is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Amos Douvdevani has authored 101 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Immunology, 19 papers in Molecular Biology and 18 papers in Oncology. Recurrent topics in Amos Douvdevani's work include Immune Cell Function and Interaction (16 papers), Cancer Genomics and Diagnostics (15 papers) and Dialysis and Renal Disease Management (11 papers). Amos Douvdevani is often cited by papers focused on Immune Cell Function and Interaction (16 papers), Cancer Genomics and Diagnostics (15 papers) and Dialysis and Renal Disease Management (11 papers). Amos Douvdevani collaborates with scholars based in Israel, United States and Germany. Amos Douvdevani's co-authors include Cidio Chaimovitz, Shraga Shany, M. Cohen, Michael Hausmann, David Czeiger, Gad Shaked, Yoram Shapira, Moshe Zlotnik, Boris Rogachev and Ron N. Apte and has published in prestigious journals such as PLoS ONE, Annals of Surgery and Scientific Reports.

In The Last Decade

Amos Douvdevani

99 papers receiving 2.8k citations

Peers

Countries citing papers authored by Amos Douvdevani

Since Specialization

Citations

This map shows the geographic impact of Amos Douvdevani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amos Douvdevani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amos Douvdevani more than expected).

Fields of papers citing papers by Amos Douvdevani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amos Douvdevani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amos Douvdevani. The network helps show where Amos Douvdevani may publish in the future.

Co-authorship network of co-authors of Amos Douvdevani

This figure shows the co-authorship network connecting the top 25 collaborators of Amos Douvdevani. A scholar is included among the top collaborators of Amos Douvdevani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amos Douvdevani. Amos Douvdevani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Admission Circulating Cell‐Free DNA Levels as a Prognostic Factor in Pediatric Burns 2022 ·BioMed Research International ·(unknown), (unknown), Nadav Sharon, Yuval Krieger, Eldad Silberstein, (unknown), Amos Douvdevani, Yaron Shoham	2
2	A prospective cohort study of dynamic cell-free DNA elevation during cardiac surgery with cardiopulmonary bypass 2022 ·PLoS ONE ·(unknown), Muhammad Abu Tailakh, (unknown), (unknown), (unknown), Oren Lev‐Ran, (unknown), Amos Douvdevani	1
3	Cell-free DNA concentration in patients with clinical or mammographic suspicion of breast cancer 2020 ·Scientific Reports ·(unknown), (unknown), David Czeiger, Samuel Ariad, Reut Riff, (unknown), (unknown), Victor Novack, (unknown), (unknown), Amos Douvdevani	25
4	Elevated Circulating Cell-Free DNA in Hemodialysis-Treated Patients Is Associated with Increased Mortality 2020 ·American Journal of Nephrology ·Yael Einbinder, Alla Shnaider, (unknown), (unknown), Boris Rogachev, Yotam Lior, Yosef S. Haviv, Keren Cohen‐Hagai, (unknown), (unknown), Sydney Benchetrit, Tali Zitman‐Gal, Amos Douvdevani	10
5	The role of cell-free DNA measured by a fluorescent test in the management of isolated traumatic head injuries 2014 ·Scandinavian Journal of Trauma Resuscitation and Emergency Medicine ·Gad Shaked, Amos Douvdevani, (unknown), Alexander Zlotnik, David Czeiger	23
6	Decrease in cell free DNA levels following participation in stress reduction techniques among women undergoing infertility treatment 2014 ·Archives of Women s Mental Health ·Johanna Czamanski‐Cohen, Orly Sarid, Julie Cwikel, Eliahu Levitas, Eitan Lunenfeld, Amos Douvdevani, Iris Har‐Vardi	29
7	Characterization of natural human antagonistic soluble CD40 isoforms produced through alternative splicing 2008 ·Molecular Immunology ·Dani Eshel, Amir Toporik, (unknown), (unknown), (unknown), Amos Douvdevani	25
8	Adenosine in burn blister fluid 2007 ·Burns ·Gad Shaked, Reuven Gurfinkel, David Czeiger, Amos Douvdevani, (unknown)	8
9	Involvement of graft-derived interleukin-15 in islet allograft rejection in mice☆ 2006 ·Cytokine ·Eli C. Lewis, (unknown), Noa Tejman-Yarden, (unknown), (unknown), Cidio Chaimovitz, Amos Douvdevani	4
10	Adenosine is upregulated during peritonitis and is involved in downregulation of inflammation 2006 ·Kidney International ·Boris Rogachev, (unknown), (unknown), (unknown), Cidio Chaimovitz, Moshe Zlotnik, Amos Douvdevani	21
11	CD40 ligand (CD154) takes part in regulation of the transition to mononuclear cell dominance during peritonitis 2005 ·Kidney International ·(unknown), Timna Agur, Boris Rogachev, (unknown), Moshe Zlotnik, Cidio Chaimovitz, Amos Douvdevani	10
12	Correction of anemia in uremic mice by genetically modified peritoneal mesothelial cells 2003 ·Kidney International ·(unknown), (unknown), (unknown), Gérardo Byk, Jutta Paßlick-Deetjen, Cidio Chaimovitz, Amos Douvdevani	17
13	The In Vitro Effects of Ketamine at Large Concentrations Can Be Attributed to a Nonspecific Cytostatic Effect 2001 ·Anesthesia & Analgesia ·Eli Lewis, Boris Rogachev, (unknown), Amos Douvdevani	17
14	Regulation of TNF-α by 1α,25-dihydroxyvitamin D3 in human macrophages from CAPD patients 2001 ·Kidney International ·M. Cohen, Amos Douvdevani, Cidio Chaimovitz, (unknown)	52
15	CD40 Ligation Enhances IL-15 Production by Tubular Epithelial Cells 2001 ·Journal of the American Society of Nephrology ·(unknown), Leonid Kachko, Cidio Chaimovitz, Cees van Kooten, Amos Douvdevani	30
16	Accessory role of human peritoneal mesothelial cells in antigen presentation and T-cell growth 2000 ·Kidney International ·Michael Hausmann, Boris Rogachev, (unknown), Cidio Chaimovitz, Amos Douvdevani	0
17	Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releasing hormone antagonist SB-75: Role of apoptosis 1994 ·American Journal of Obstetrics and Gynecology ·D. Kleinman, Amos Douvdevani, Andrew V. Schally, Joseph Levy, Yoav Sharoni	59
18	Different regulatory levels are involved in the generation of hemopoietic cytokines (CSFs and IL-6) in fibroblasts stimulated by inflammatory products 1993 ·Cytokine ·Mahmoud Huleihel, Amos Douvdevani, Shraga Segal, Ron N. Apte	27
19	Interleukin‐1 production by transformed fibroblasts. II. Influence on antigen presentation and T‐cell‐mediated anti‐tumor response 1992 ·International Journal of Cancer ·Margot Zöller, Amos Douvdevani, Shraga Segal, Ron N. Apte	24
20	Regulation of interleukin 1 generation in immune‐activated fibroblasts 1990 ·European Journal of Immunology ·Mahmoud Huleihel, Amos Douvdevani, Shraga Segal, Ron N. Apte	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact